Introduction: Aquaculture is increasingly constrained by disease outbreaks and the unsustainable use of antibiotics, necessitating alternative health management strategies. This study presents an integrated pipeline from discovery to in vivo validation of indigenous probiotic bacteria for Nile tilapia aquaculture.
Materials and Methods: A novel, non-invasive isolation approach using minimal media supplemented with N-hexanoyl homoserine lactone (HHL) enabled targeted recovery of quorum-quenching bacteria from aquaculture sediments. Selected strains were evaluated for environmental robustness, probiotic functionality, and biosafety using zebrafish (Danio rerio) embryos and Artemia models.
A 60-day feeding trial under controlled conditions was conducted with juvenile Nile tilapia supplemented with Lysinibacillus fusiformis LFUG and Priestia megaterium PMUG01 at 106 and 108 CFU·g-1 of feed. Growth performance, feed conversion efficiency (FCE), gut microbiome composition, and resistance to a 14-days Providencia sp. challenge were assessed.
Results and Discussion: Selected strains exhibited high tolerance to temperature (85¡C) and salinity (35g.L-1), alongside non-haemolytic activity, proteolytic capacity, and broad metabolic versatility. Identified taxa included P. megaterium (PMUG01 and PMUG02), L. fusiformis (LFUG), Micrococcus yunnanensis (MYUG), and two putative novel species (Kocuria crassamentum sp. nov. and Heyndrickxia crassamentum sp. nov.). Probiotic supplementation improved growth performance, feed conversion efficiency, and size uniformity compared to controls (Table 1). The gut microbiome of treated fish was enriched with potentially beneficial bacteria, whereas control fish were dominated by likely opportunistic bacteria. Disease resistance was enhanced (survival >50%), and histological analyses confirmed preservation of gut, spleen, and liver integrity following 7 days of pathogen exposure (Fig. 1).
Conclusion: Local probiotics selected through a targeted quorum-quenching-based discovery pipeline enhance growth performance and FCE, modulate host-microbe interactions, and improve disease resilience in Nile tilapia, providing a strong foundation for sustainable aquaculture health management strategies.